Terms: = Squamous Cell Carcinoma AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Prognosis
793 results:
1. Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma.
Dong S; Zhao M; Zhu J; Li T; Yan M; Xing K; Liu P; Yu S; Ma J; He H
Front Immunol; 2024; 15():1442673. PubMed ID: 39234249
[TBL] [Abstract] [Full Text] [Related]
2. Multispectral fluorescence imaging of egfr and PD-L1 for precision detection of oral squamous cell carcinoma: a preclinical and clinical study.
Jin N; An Y; Tian Y; Zhang Z; He K; Chi C; Mu W; Tian J; Du Y
BMC Med; 2024 Aug; 22(1):342. PubMed ID: 39183296
[TBL] [Abstract] [Full Text] [Related]
3. The efficacy and potential mechanisms of pyrotinib in targeting egfr and HER2 in advanced oral squamous cell carcinoma.
Zhou L; Le K; Chen Q; Wang H
BMC Oral Health; 2024 Aug; 24(1):898. PubMed ID: 39107736
[TBL] [Abstract] [Full Text] [Related]
4. Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database.
Cabart M; Mourey L; Pasquier D; Schneider S; Léna H; Girard N; Chouaid C; Schott R; Hiret S; Debieuvre D; Quantin X; Madroszyk A; Dubray-Longeras P; Pichon E; Baranzelli A; Justeau G; Pérol M; Bosquet L; Cabarrou B
J Geriatr Oncol; 2024 Sep; 15(7):101819. PubMed ID: 39068144
[TBL] [Abstract] [Full Text] [Related]
5. p16, p53 and egfr expression in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters.
Gupta S; Pandey P; Verma S; Verma A
J Cancer Res Ther; 2024 Apr; 20(3):881-887. PubMed ID: 39023595
[TBL] [Abstract] [Full Text] [Related]
6. Unveiling the regulatory mechanism of nimotuzumab on PD-L1 expression in head and neck squamous cell carcinoma patients: Implications for enhanced anticancer treatment strategies.
Hu M; Tang B; Dai Y; Zhao X
Cell Signal; 2024 Sep; 121():111290. PubMed ID: 38977231
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous carcinoma: Results From a Nationwide Japanese Registry Data.
Hishida T; Okami J; Asamura H; Miyaoka E; Shintani Y; Kadokura M; Endo S; Chida M; Suzuki H; Yoshino I; Date H;
Clin Lung Cancer; 2024 Sep; 25(6):519-528.e3. PubMed ID: 38906754
[TBL] [Abstract] [Full Text] [Related]
8. Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of egfr signaling.
Zhang Y; Yang W; Han X; Qiao Y; Wang H; Chen T; Li T; Ou WB
Oncol Res; 2024; 32(6):1119-1128. PubMed ID: 38827327
[TBL] [Abstract] [Full Text] [Related]
9. Near-infrared imaging of head and neck squamous cell carcinoma using indocyanine green that targets the
Yuan Y; Fan T; Wang J; Yuan Y; Tao X
J Biomed Opt; 2024 Apr; 29(4):046002. PubMed ID: 38633382
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of Some Prognostic Biomarkers in Human Papillomavirus-Related Multiphenotypic Sinonasal carcinoma.
Alabiad MA; Said WMM; Adim AMA; Alorini M; Shalaby AM; Samy W; Elshorbagy S; Mandour D; Saber IM; Yahia AIO; Khairy DA
Iran J Med Sci; 2024 Mar; 49(3):156-166. PubMed ID: 38584650
[TBL] [Abstract] [Full Text] [Related]
11. egfr overexpression and macrophage infiltration correlate with poorer prognosis in HPV-negative oropharyngeal cancer via STAT6 signaling.
Lee HP; Li CJ; Lee CC
Head Neck; 2024 Jun; 46(6):1294-1303. PubMed ID: 38497289
[TBL] [Abstract] [Full Text] [Related]
12. Molecular and nutritional markers in head and neck cancer.
Milano G; Gal J; Bensadoun RJ
Curr Opin Oncol; 2024 May; 36(3):123-127. PubMed ID: 38441194
[TBL] [Abstract] [Full Text] [Related]
13. STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial.
Baptiste Oudart J; Garinet S; Leger C; Barlesi F; Mazières J; Jeannin G; Audigier-Valette C; Morot-Sibilot D; Langlais A; Amour E; Mathiot N; Birsen G; Blons H; Wislez M
Lung Cancer; 2024 Apr; 190():107508. PubMed ID: 38428265
[TBL] [Abstract] [Full Text] [Related]
14. Expression of egfr and p16 in squamous cell carcinoma of External Auditory Canal.
Kajimoto Y; Shinomiya H; Uehara N; Teshima M; Fujita T; Kakigi A; Imamura Y; Kiyota N; Miyawaki D; Sasaki R; Kimura H; Nibu KI
Kobe J Med Sci; 2024 Jan; 69(4):E144-E150. PubMed ID: 38379276
[TBL] [Abstract] [Full Text] [Related]
15. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
[TBL] [Abstract] [Full Text] [Related]
16. Study of the association of the known prognostic variables with egfr expression in head and neck squamous cell carcinomas.
Jadhav T; Malik A; Kashif AW; Shelly D; Mishra PS; Baranwal AK; Sahu R
Indian J Pathol Microbiol; 2024; 67(1):36-45. PubMed ID: 38358186
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer.
Wang L; Diao M; Zhang Z; Jiang M; Chen S; Zhao D; Liu Z; Zhou C
Lung Cancer; 2024 Jan; 187():107439. PubMed ID: 38113653
[TBL] [Abstract] [Full Text] [Related]
18. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of egfr/PI3K/AKT/mTOR pathway.
Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X
Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
[TBL] [Abstract] [Full Text] [Related]
19. Identify and validate circadian regulators as potential prognostic markers and immune infiltrates in head and neck squamous cell carcinoma.
Jin Y; Wang Z; Huang S; Liu C; Wu X; Wang H
Sci Rep; 2023 Nov; 13(1):19939. PubMed ID: 37968308
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of RAB27A in Oral squamous cell carcinoma Promotes Tumor Migration and Invasion via Modulation of egfr Membrane Stability.
Huang J; Yang JG; Ren JG; Xia HF; Chen GH; Fu QY; Zhang LZ; Liu HM; Wang KM; Xie QH; Chen G
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685910
[TBL] [Abstract] [Full Text] [Related]
[Next]
